<i>Syzygium aromaticum</i> Attenuates Cerebellar Oxidative Stress: An Integrated in silico, in vitro, and in vivo Evaluation of Multi-Target Antioxidant Mechanisms.
Overview
- Department of Anatomy, Kampala International University Western Campus, Ishaka-Bushenyi, Uganda
- Anatomy Department, School of Medicine and Pharmacy, University of Rwanda, Butare, Rwanda
- Department of Biochemistry, Kampala International University Western Campus, Ishaka-Bushenyi, Uganda
Abstract
Introduction: The central role of oxidative stress in neuronal injury and the progression of neurological disorders underscores the need to identify multi-target agents capable of restoring redox homeostasis. This study evaluated the antioxidant and pharmacological potential of Syzygium aromaticum ethyl acetate fraction (SEAF) using integrated phytochemical, computational, and experimental approaches.
Methods: GC-MS was used to characterize the phytochemical composition of the ethyl acetate fraction of Syzygium aromaticum (SEAF). Thirteen phytometabolites with relative peak areas ≥1.0% were selected for ADME-Tox profiling and molecular docking against monoamine oxidase B (MAO-B) and 5-lipoxygenase (5-LOX). In vitro antioxidant assays, acute oral toxicity testing, and in vivo evaluation of cerebellar oxidative stress biomarkers were subsequently performed.
Results: GC-MS identified eugenyl acetate (43.08%), eugenol (18.86%), and β-caryophyllene (1.64%) as the predominant metabolites. The prioritized phytometabolites exhibited favorable predicted ADME-Tox profiles and notable binding energies for MAO-B (up to −8.4 kcal/
Conclusion: Syzygium aromaticum exhibited potent antioxidant effects through combined radical scavenging, enzymatic enhancement, modulation of oxidative stress-related targets, and preservation of cerebellar histoarchitecture, supporting its potential as a candidate for further preclinical development.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- figshare:32920373, at figshare; found in the references
Data Sharing Statement
The dataset related to this study will be available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 8 authors, 5 keywords, 62 references.
Cite
This paper
Etukudo, E. M., Usman, I. M., Oviosun, A., Ojiakor, V. O., Makena, W., Owembabazi, E., Aja, P. M., & Anyanwu, E. (2026). &
BibTeX
@article{etukudo2026lt,
author = {Etukudo, Ekom Monday and Usman, Ibe Michael and Oviosun, Augustine and Ojiakor, Vivian Onyinye and Makena, Wusa and Owembabazi, Elna and Aja, Patrick Maduabuchi and Anyanwu, Emeka},
title = {{\&
journal = {Journal of experimental pharmacology},
year = {2026},
month = sep,
volume = {18},
pages = {630837},
publisher = {Dove Press},
issn = {1179-1454},
doi = {10.2147/
url = {https://
pmid = {42701812},
pmcid = {PMC13546071}
}
RIS
TY - JOUR
AU - Etukudo, Ekom Monday
AU - Usman, Ibe Michael
AU - Oviosun, Augustine
AU - Ojiakor, Vivian Onyinye
AU - Makena, Wusa
AU - Owembabazi, Elna
AU - Aja, Patrick Maduabuchi
AU - Anyanwu, Emeka
TI - &
T2 - Journal of experimental pharmacology
J2 - J Exp Pharmacol
PY - 2026
DA - 2026/
VL - 18
SP - 630837
SN - 1179-1454
PB - Dove Press
DO - 10.2147/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.2147/
"type": "article-journal",
"title": "&
"container-title": "Journal of experimental pharmacology",
"author": [
{
"family": "Etukudo",
"given": "Ekom Monday"
},
{
"family": "Usman",
"given": "Ibe Michael"
},
{
"family": "Oviosun",
"given": "Augustine"
},
{
"family": "Ojiakor",
"given": "Vivian Onyinye"
},
{
"family": "Makena",
"given": "Wusa"
},
{
"family": "Owembabazi",
"given": "Elna"
},
{
"family": "Aja",
"given": "Patrick Maduabuchi"
},
{
"family": "Anyanwu",
"given": "Emeka"
}
],
"container-title-short":
"volume": "18",
"page": "630837",
"DOI": "10.2147/
"PMID": "42701812",
"PMCID": "PMC13546071",
"ISSN": "1179-1454",
"publisher": "Dove Press",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
1
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/biology15110867
- Differential Activation of Pro-Survival Pathways by NIX/
BNIP3L: An Expression-Level-Depende nt Mechanism Governing PC12 Cell Fate During H& lt;sub& gt;2& lt;/ sub& gt;O& lt;sub& gt;2& lt;/ sub& gt;-Induced Oxidative Stress. Journal: BiologyIn common: cellular / molecular, 1 reference - [2] doi:10.3389/fendo.2026.1819985
- Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/
6 mouse model. Journal: Frontiers in endocrinologyIn common: cellular / molecular, 1 reference - [3] doi:10.1080/07853890.2026.2663133
- Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage.Journal: Annals of medicineIn common: cellular / molecular, 1 reference
- [4] doi:10.1016/j.ebiom.2026.106362 [code]
- Neuron-derived neurotrophic factor-positive interneurons: a cellular target for anti-seizure therapies.Journal: EBioMedicineIn common: 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
